Search results

Evidence-based recommendations on Sleepio to treat insomnia and insomnia symptoms

Type

Medical technologies guidance

Published

20 May 2022

This guideline aims to increase the uptake of all vaccines provided on the NHS routine UK immunisation schedule by everyone who is eligible. It supports the aims of the NHS Long Term Plan , which includes actions to improve immunisation coverage by GPs (including the changes to vaccinations and immunisations detailed in the 2021/2022 and 2022/23 GP contracts ) and support a narrowing of health inequalities.

Type

NICE guideline

Published

17 May 2022

Evidence-based recommendations on selumetinib (Koselugo) for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 and over

Type

Highly specialised technologies guidance

Published

05 May 2022

Evidence-based recommendations on elosulfase alfa (Vimizim) for treating mucopolysaccharidosis type 4A in people of all ages

Type

Highly specialised technologies guidance

Published

20 April 2022

Evidence-based recommendations on myCOPD for managing chronic obstructive pulmonary disease

Type

Medical technologies guidance

Published

31 March 2022

Evidence-based recommendations on UroShield for preventing catheter-associated urinary tract infections

Type

Medical technologies guidance

Published

31 March 2022

Evidence-based recommendations on atidarsagene autotemcel (Libmeldy) for treating metachromatic leukodystrophy in children

Type

Highly specialised technologies guidance

Published

28 March 2022

This guideline covers providing integrated health and social care services for people experiencing homelessness. It aims to improve access to and engagement with health and social care, and ensure care is coordinated across different services.

Type

NICE guideline

Published

16 March 2022

This guideline sets out an antimicrobial prescribing strategy for acute otitis media (ear infection). It aims to limit antibiotic use and reduce antimicrobial resistance. Acute otitis media can be caused by viruses or bacteria. It lasts for about a week, and most children get better in 3 days without antibiotics. Serious complications are rare.

Type

Antimicrobial prescribing guideline

Last updated

11 March 2022

Evidence-based recommendations on Prontosan for treating acute and chronic wounds

Type

Medical technologies guidance

Published

08 March 2022

Evidence-based recommendations on 3C Patch for treating diabetic foot ulcers

Type

Medical technologies guidance

Published

07 March 2022

This guideline covers how to create the right conditions for mental wellbeing at work. It aims to promote a supportive and inclusive work environment, including training and support for managers and helping people who have or are at risk of poor mental health.

Type

NICE guideline

Published

02 March 2022

Evidence-based recommendations on odevixibat (Bylvay) for treating progressive familial intrahepatic cholestasis in people 6 months and older

Type

Highly specialised technologies guidance

Published

22 February 2022

Evidence-based recommendations on Sedaconda ACD-S for sedation with volatile anaesthetics in intensive care

Type

Medical technologies guidance

Published

27 January 2022

Evidence-based recommendations on KardiaMobile for detecting atrial fibrillation

Type

Medical technologies guidance

Published

06 January 2022

Evidence-based recommendations on Endo-SPONGE for treating low rectal anastomotic leak

Type

Medical technologies guidance

Published

16 December 2021

Evidence-based recommendations on ClearGuard HD antimicrobial barrier caps for preventing haemodialysis catheter-related bloodstream infections

Type

Medical technologies guidance

Published

13 December 2021

Evidence-based recommendations on Synergo for non-muscle-invasive bladder cancer

Type

Medical technologies guidance

Published

30 November 2021

This guideline covers support to stop smoking for everyone aged 12 and over, and help to reduce people's harm from smoking if they are not ready to stop in one go . It also covers ways to prevent children, young people and young adults aged 24 and under from taking up smoking. The guideline brings together and updates all NICE's previous guidelines on using tobacco, including smokeless tobacco . It covers nicotine replacement therapy and e-cigarettes to help people stop smoking or reduce their harm from smoking. It does not cover using tobacco products such as ‘heat not burn’ tobacco.

Type

NICE guideline

Published

30 November 2021

Evidence-based recommendations on givosiran (Givlaari) for treating acute hepatic porphyria in adults and young people aged 12 and over

Type

Highly specialised technologies guidance

Published

24 November 2021

This guideline covers how organisations, practitioners and carers should work together to deliver high-quality care, stable placements and nurturing relationships for looked-after children and young people. It aims to help these children and young people reach their full potential and have the same opportunities as their peers.

Type

NICE guideline

Published

20 October 2021

Evidence-based recommendations on DyeVert Systems for reducing the risk of acute kidney injury in coronary and peripheral angiography

Type

Medical technologies guidance

Published

04 October 2021

This guideline sets out an antimicrobial prescribing strategy for managing Clostridioides difficile infection in adults, young people and children aged 72 hours and over in community and hospital settings. It aims to optimise antibiotic use and reduce antibiotic resistance. The recommendations do not cover diagnosis.

Type

Antimicrobial prescribing guideline

Published

23 July 2021

Evidence-based recommendations on ENDURALIFE-powered CRT-D devices for treating heart failure

Type

Medical technologies guidance

Last updated

21 July 2021

Evidence-based recommendations on onasemnogene abeparvovec (Zolgensma) for treating spinal muscular atrophy in babies

Type

Highly specialised technologies guidance

Published

07 July 2021

Evidence-based recommendations on Plus Sutures for preventing surgical site infection

Type

Medical technologies guidance

Published

28 June 2021

Evidence-based recommendations on HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography

Type

Medical technologies guidance

Last updated

19 May 2021

Evidence-based recommendations on Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcers

Type

Medical technologies guidance

Last updated

19 May 2021

Evidence-based recommendations on UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia

Type

Medical technologies guidance

Published

04 May 2021

Evidence-based recommendations on Danis stent for acute oesophageal variceal bleeding

Type

Medical technologies guidance

Published

31 March 2021

Evidence-based recommendations on Alpha-Stim AID for anxiety disorders

Type

Medical technologies guidance

Published

08 March 2021

This guideline sets out an antimicrobial prescribing strategy for secondary bacterial infection of eczema and covers infection of other common skin conditions. It aims to optimise antibiotic use and reduce antibiotic resistance. The recommendations are for adults, young people and children aged 72 hours and over. They do not cover diagnosis.

Type

Antimicrobial prescribing guideline

Published

02 March 2021

Evidence-based recommendations on metreleptin (Myalepta) for treating lipodystrophy in children and adults

Type

Highly specialised technologies guidance

Published

24 February 2021

Evidence-based recommendations on Leukomed Sorbact for preventing surgical site infection after caesarean section or vascular surgery

Type

Medical technologies guidance

Published

03 February 2021

Evidence-based recommendations on the VAC Veraflo Therapy system for acute infected or chronic wounds that are failing to heal

Type

Medical technologies guidance

Published

27 January 2021

Evidence-based recommendations on the PLASMA system for transurethral resection and haemostasis of the prostate

Type

Medical technologies guidance

Published

06 January 2021

Evidence-based recommendations on Zio XT for detecting cardiac arrhythmias

Type

Medical technologies guidance

Published

01 December 2020

This guideline sets out an antimicrobial prescribing strategy for human and animal bites (excluding insect bites) in adults, young people and children aged 72 hours and over. It aims to optimise antibiotic use and reduce antibiotic resistance.

Type

Antimicrobial prescribing guideline

Published

04 November 2020

Evidence-based recommendations on volanesorsen (Waylivra) for treating familial chylomicronaemia syndrome in adults

Type

Highly specialised technologies guidance

Published

21 October 2020

Evidence-based recommendations on SEM Scanner 200 for preventing pressure ulcers

Type

Medical technologies guidance

Published

14 October 2020

This guideline covers interventions that use a digital or mobile platform to help people eat more healthily, become more active, stop smoking, reduce their alcohol intake or practise safer sex. The interventions include those delivered by text message, apps, wearable devices or the internet. The guideline only includes those that are delivered by the technology itself and not by healthcare professionals using technology to deliver interventions.

Type

NICE guideline

Published

07 October 2020

This guideline sets out an antimicrobial prescribing strategy for insect and spider bites and stings in adults, young people and children aged 72 hours and over, including those that occurred while travelling outside the UK. It aims to limit antibiotic use and reduce antibiotic resistance.

Type

Antimicrobial prescribing guideline

Published

22 September 2020

Evidence-based recommendations on Axonics sacral neuromodulation system for treating refractory overactive bladder

Type

Medical technologies guidance

Published

03 September 2020

Evidence-based recommendations on Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia

Type

Medical technologies guidance

Published

24 June 2020

Evidence-based recommendations on PneuX to prevent ventilator-associated pneumonia

Type

Medical technologies guidance

Published

08 April 2020

This guideline sets out an antimicrobial prescribing strategy for adults, young people and children aged 72 hours and over with impetigo. It aims to optimise antibiotic use and reduce antibiotic resistance.

Type

Antimicrobial prescribing guideline

Published

26 February 2020

This guideline sets out an antimicrobial prescribing strategy for adults with leg ulcer infection. It aims to optimise antibiotic use and reduce antibiotic resistance.

Type

Antimicrobial prescribing guideline

Published

11 February 2020

Evidence-based recommendations on Episcissors-60 for mediolateral episiotomy

Type

Medical technologies guidance

Published

11 February 2020

Evidence-based recommendations on Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C

Type

Medical technologies guidance

Last updated

17 January 2020

This guideline covers indoor air quality in residential buildings. It aims to raise awareness of the importance of good air quality in people's homes and how to achieve this.

Type

NICE guideline

Published

08 January 2020